✦ LIBER ✦

High sustained virologic response rates in children with chronic hepatitis C receiving peginterferon alfa-2b plus ribavirin

✍ Scribed by Stefan Wirth; Carmen Ribes-Koninckx; Maria Angeles Calzado; Flavia Bortolotti; Lucia Zancan; Paloma Jara; Mark Shelton; Nanda Kerkar; Marcela Galoppo; Alejandra Pedreira; Norberto Rodriguez-Baez; Mirta Ciocca; Alain Lachaux; Florence Lacaille; Thomas Lang; Ulrike Kullmer; Wolf Dietrich Huber; Teresita Gonzalez; Henry Pollack; Estella Alonso; Pierre Broue; Jyoti Ramakrishna; Deborah Neigut; Antonio del Valle-Segarra; Bessie Hunter; Zachery Goodman; Christine R. Xu; Hanzhe Zheng; Stephanie Noviello; Vilma Sniukiene; Clifford Brass; Janice K. Albrecht

Book ID: 118475423
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 517 KB
Volume: 52
Category: Article
ISSN: 0168-8278
DOI: 10.1016/j.jhep.2010.01.016

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Early virologic response to treatment wi

Early virologic response to treatment with peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C

✍ Gary L. Davis; John B. Wong; John G. McHutchison; Michael P. Manns; Joann Harvey 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 129 KB

Peginterferon alfa-2b plus ribavirin tre

Peginterferon alfa-2b plus ribavirin treatment in children and adolescents with chronic hepatitis C

✍ Stefan Wirth; Heidrun Pieper-Boustani; Thomas Lang; Antje Ballauff; Ulrike Kullm 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 107 KB 👁 2 views

Peginterferon plus ribavirin is standard therapy for adults with chronic hepatitis C. As no data are available for children, the aim of the study was to evaluate the efficacy and tolerability of peginterferon alfa-2b in combination with ribavirin in chronically infected children. Genotypes, alanine

Early virologic response after peginterf

Early virologic response after peginterferon alpha-2a plus ribavirin or peginterferon alpha-2b plus ribavirin treatment in patients with chronic hepatitis C

✍ A. M. Di Bisceglie; R. H. Ghalib; F. M. Hamzeh; V. K. Rustgi 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 547 KB

Predicting sustained virological respons

Predicting sustained virological response and anaemia in chronic hepatitis C patients treated with peginterferon alfa-2a (40KD) plus ribavirin

✍ Eric Snoeck; Janet R. Wade; Frank Duff; Matthew Lamb; Karin Jorga 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 739 KB

Predicting sustained virological respons

Predicting sustained virological responses in chronic hepatitis C patients treated with peginterferon alfa-2a (40 KD)/ribavirin

✍ Peter Ferenci; Michael W. Fried; Mitchell L. Shiffman; Coleman I. Smith; George 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 182 KB

481 FOUR-WEEK THERAPY WITH PEGINTERFERON

481 FOUR-WEEK THERAPY WITH PEGINTERFERON ALFA-2B/ RIBAVIRIN EFFECTIVELY PREDICTS SUSTAINED VIROLOGIC RESPONSE IN TREATMENT-NAIVE AND PREVIOUS-TREATMENT-FAILURE PATIENTS WITH HCV-1 TREATED WITH BOCEPREVIR PLUS PEGINTERFERON ALFA-2B/RIBAVIRIN

✍ J.M. Vierling; E.J. Lawitz; F. Poordad; M.S. Sulkowski; M. Bourliere; M. Buti; C 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 42 KB